Optical Sensor for Photodynamic Detection of Oral Pathology
NCT ID: NCT00540774
Last Updated: 2025-12-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
SUSPENDED
NA
2500 participants
INTERVENTIONAL
2003-04-30
2028-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
We are recruiting patients with a wide range of oral conditions including plaque, dry mouth, toothache, root canal treatments, gum disease, oral sores, dysplasia and cancer, autoimmune conditions and others as well as healthy control subjects. We will use a range of non-invasive imaging modalities to obtain information on the ways in which the oral health status affects optical properties, and determine means of detecting and quantifying these factors.. Imaging modalities to be utilized include:
1. Coherence and Doppler Tomography
2. Laser Speckle Imaging
3. Various forms of Spectroscopy
4. Fluorescence
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Hypothesis: microstructural, metabolic, vascular, protein, genomic and metabolomics biomarkers of oral pathology can be used to detect, predict and map oral pathology, especially neoplasia.
Researchers of the Beckman Laser Institute (BLI) have developed many non-invasive imaging modalities for assessment of oral tissue. This protocol will allow data acquisition with these multiple modalities to allow validation of data. Imaging modalities to be utilized include:
1. Coherence and Doppler Tomography (OCT)
2. Laser Speckle Imaging (LSI)
3. Photon Migration Spectroscopy (PMS)
4. Autofluorescence Imaging
In addition, saliva samples from the patients will be analyzed and the resulting data regarding the dysregulation in the activities of genes, proteins and other molecules will be correlated with findings from different imaging systems with respect to the stage of oral carcinogenesis.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
DIAGNOSTIC
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Oral tissue
Imaging of oral structures and pathologies
detection of oral pathology
detection of oral pathology
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
detection of oral pathology
detection of oral pathology
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Have oral lesion or not have oral lesion
* Have condition of dry mouth
* Have condition of Gum disease
* Non-smoker
Exclusion Criteria
* Advanced gum disease, diseases of oral tissue
* Untreated cavities
* Pregnant or breastfeeding
* Immune compromised individuals
18 Years
75 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
NIH
National Institute of Dental and Craniofacial Research (NIDCR)
NIH
Livionex Inc.
INDUSTRY
Orahealth
UNKNOWN
National Cancer Institute (NCI)
NIH
University of California, Irvine
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Petra E. Wilder-Smith
Professor of Surgery and Director of Dentistry
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Petra Wilder-Smith, DDS, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Calfornia Irvine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Beckman Laser Institute and Medical Clinic
Irvine, California, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20022805
Identifier Type: -
Identifier Source: org_study_id
T31IR1825
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
LDG
Identifier Type: OTHER
Identifier Source: secondary_id
OE
Identifier Type: OTHER
Identifier Source: secondary_id
UCI-08-52
Identifier Type: OTHER
Identifier Source: secondary_id